Aurobindo Pharma reported INR927.7M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Cipla INR 140.3M 8.5M Dec/2025
Divis Laboratories Ltd INR 60M 30M Dec/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Hindustan Unilever INR 880M 410M Dec/2025
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
UPL INR 7.74B 210M Dec/2025